Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

804 results

Medicine type Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter Biosimilar Remove Biosimilar filter Orphan medicine Remove Orphan medicine filter

Medicine Orphan designations Remove Orphan designations filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Sort by

List item

Human medicine European public assessment report (EPAR): Jorveza (updated)

budesonide, Esophageal Diseases
Date of authorisation: 08/01/2018, , , Revision: 6, Authorised, Last updated: 06/12/2022
List item

Human medicine European public assessment report (EPAR): Zytiga (updated)

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 05/09/2011, , Revision: 26, Authorised, Last updated: 06/12/2022
List item

Human medicine European public assessment report (EPAR): Nexavar (updated)

sorafenib, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 19/07/2006, , Revision: 32, Authorised, Last updated: 06/12/2022
List item

Human medicine European public assessment report (EPAR): Ngenla (updated)

somatrogon, Growth and Development
Date of authorisation: 14/02/2022, , , Revision: 4, Authorised, Last updated: 06/12/2022
List item

Human medicine European public assessment report (EPAR): Striascan (updated)

ioflupane (123l), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 25/06/2019, , Revision: 2, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Cabometyx (updated)

cabozantinib (s)-malate, Carcinoma, Renal Cell; Carcinomas, Hepatocellular
Date of authorisation: 09/09/2016, , Revision: 15, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Pyrukynd (updated)

mitapivat sulfate, Genetic Diseases, Inborn; Anemia, Hemolytic
Date of authorisation: 09/11/2022, , , Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Hulio (updated)

adalimumab, Hidradenitis Suppurativa; Psoriasis; Uveitis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic
Date of authorisation: 17/09/2018, , , Revision: 13, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)

efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018, , Revision: 9, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Pemazyre (updated)

pemigatinib, Cholangiocarcinoma
Date of authorisation: 26/03/2021, , , , Revision: 4, Authorised, Last updated: 02/12/2022
List item

Human medicine European public assessment report (EPAR): Tecartus (updated)

Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel), Lymphoma, Mantle-Cell
Date of authorisation: 14/12/2020, , , , Revision: 3, Authorised, Last updated: 02/12/2022
List item

Human medicine European public assessment report (EPAR): Dexmedetomidine Accord (updated)

dexmedetomidine, Premedication
Date of authorisation: 13/02/2020, , Revision: 5, Authorised, Last updated: 02/12/2022
List item

Human medicine European public assessment report (EPAR): Livtencity (updated)

Maribavir, Cytomegalovirus Infections
Date of authorisation: 09/11/2022, , , Authorised, Last updated: 01/12/2022
List item

Human medicine European public assessment report (EPAR): Flixabi (updated)

infliximab, Arthritis, Psoriatic; Spondylitis, Ankylosing; Colitis, Ulcerative; Arthritis, Rheumatoid; Crohn Disease; Psoriasis
Date of authorisation: 26/05/2016, , Revision: 22, Authorised, Last updated: 01/12/2022
List item

Human medicine European public assessment report (EPAR): Mysildecard (updated)

sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016, , Revision: 7, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016, , , , Revision: 14, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Zynteglo (updated)

Autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019, , , , , Revision: 5, Withdrawn, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Lacosamide Accord (updated)

lacosamide, Epilepsy
Date of authorisation: 18/09/2017, , Revision: 11, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Blitzima (updated)

rituximab, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017, , Revision: 17, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Truxima (updated)

rituximab, Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis
Date of authorisation: 17/02/2017, , Revision: 18, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Ximluci (updated)

ranibizumab, Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications
Date of authorisation: 09/11/2022, , , Authorised, Last updated: 29/11/2022
List item

Human medicine European public assessment report (EPAR): Tagrisso (updated)

osimertinib mesilate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 01/02/2016, , Revision: 17, Authorised, Last updated: 29/11/2022
List item

Human medicine European public assessment report (EPAR): Remsima (updated)

infliximab, Arthritis, Psoriatic; Spondylitis, Ankylosing; Colitis, Ulcerative; Psoriasis; Crohn Disease; Arthritis, Rheumatoid
Date of authorisation: 10/09/2013, , Revision: 30, Authorised, Last updated: 25/11/2022
List item

Human medicine European public assessment report (EPAR): Tavneos (updated)

Avacopan, Microscopic Polyangiitis; Wegener Granulomatosis
Date of authorisation: 11/01/2022, , , Revision: 1, Authorised, Last updated: 25/11/2022
List item

Human medicine European public assessment report (EPAR): Sorafenib Accord (updated)

Sorafenib tosilate, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 09/11/2022, , Authorised, Last updated: 25/11/2022